According to Sun Pharmaceutical 's latest financial reports and stock price the company's current Operating Margin is 26.08%. At the end of 2024 the company had an Operating Margin of 23.72%.
Year | Operating Margin | Change |
---|---|---|
2024 | 23.72% | 7.13% |
2023 | 22.14% | 84.57% |
2022 | 11.99% | 35.55% |
2021 | 8.85% | -46.04% |
2020 | 16.40% | 8.49% |
2019 | 15.11% | 0.22% |
2018 | 15.08% | -51.77% |
2017 | 31.27% | 25.08% |
2016 | 25.00% | 1.59% |
2015 | 24.60% | -14.42% |
2014 | 28.75% | -25.88% |
2013 | 38.79% | -8.3% |
2012 | 42.30% | 14.66% |
2011 | 36.89% | -0.69% |
2010 | 37.15% | -18.58% |
2009 | 45.62% | -4.25% |
2008 | 47.65% | 22.11% |
2007 | 39.02% | 7.01% |
2006 | 36.47% | 2.69% |
2005 | 35.51% | -8.28% |
2004 | 38.72% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.